Integration of Cannabis Extract Tetrahydrocannabinol:Cannabidiol in an Interdisciplinary Therapy Setting: A Case of Chronic Multilocular Pain Disorder

Med Cannabis Cannabinoids. 2022 Nov 22;5(1):220-225. doi: 10.1159/000527521. eCollection 2022 Jan-Dec.

Abstract

Multilocular pain syndromes with advanced chronification lead to a significant reduction in the quality of life of patients. The administration of cannabis is currently being discussed in the context of therapy-resistant pain and increasing opiate abuse. In this case study, possible side effects from the administration of a cannabis extract tetrahydrocannabinol:cannabidiol are examined. Furthermore, the effect on pain intensity and sleep quality is recorded. Due to numerous comorbidities in the patient, interactions with other medications are documented.

Keywords: Cannabis; Chronic pain; Pain; Side effects; Tetrahydrocannabinol:cannabidiol.

Publication types

  • Case Reports

Grant support

Alternative Medical Products (AMP) held out the prospect of paying the APC.